This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

CROMSOURCE Acquires PDR Partners - Expands UK Staffing Solutions Services

VERONA, Italy, October 12, 2012 /PRNewswire/ --

CROMSOURCE, an international, full-service contract research organization (CRO) today announced the acquisition of PDR Partners Ltd, an established staffing and recruitment organization with offices in Bracknell, UK.

PDR Partners was launched in 2002, supporting biopharmaceutical and medical device companies of all sizes with a complete range of flexible staffing solutions.

'We are delighted to welcome PDR Partners and its expert team,' stated Dr Oriana Zerbini, Chief Executive Officer of CROMSOURCE. 'For some time we have wanted to expand our Staffing Solutions business to further support our clients in the UK with their staffing needs. The opportunity to achieve this through the addition of the experienced and successful team from PDR Partners is of great importance to us. With this exciting collaboration CROMSOURCE reinforces its capability to support its clients with a full-service portfolio across both Europe and the USA.'

Claire Jackaman, Managing Director of PDR Partners, noted: 'We are very excited to be joining the CROMSOURCE family and working together to provide exceptional services to our current and future clients. With CROMSOURCE we share a philosophy of quality, flexibility and intense customer focus and we look forward to an exciting future together.' Claire will remain in charge of CROMSOURCE Staffing Solutions in the UK.

About CROMSOURCE:

CROMSOURCE was established in 1994 and is an ISO-certified, full-service Contract Research Organization providing clinical trial services and staffing solutions. CROMSOURCE operates across Europe, Russia, Ukraine and the USA and incorporates a high-quality early phase unit. CROMSOURCE provides One Trial One Price - a unique fixed-price guarantee which assures clients that each project will be delivered according to the contract price.

Contact:

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,387.21 -291.49 -1.65%
S&P 500 2,029.55 -27.54 -1.34%
NASDAQ 4,681.4970 -90.2660 -1.89%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs